Literature DB >> 28150915

Multicenter retrospective study on management and outcome of newborns affected by surgical necrotizing enterocolitis.

Silvana Federici1, Lorenzo DE Biagi2, Simona Straziuso1, Ernesto Leva3, Giulia Brisighelli3, Girolamo Mattioli4, Luca Pio4, Pietro Bagolan5, Giorgia Totonelli5, Bruno Noccioli6, Elisa Severi6, Pierluigi Lelli Chiesa7,8, Gabriele Lisi7,8, Antonino Tramontano9, Carolina DE Chiara9, Carmine Del Rossi10, Giovanni Casadio10, Mario Messina11, Rossella Angotti11, Antonino Appignani12, Mirko Bertozzi12, Fabio Rossi13, Valeria Gabriele13, Andrea Franchella14, Veronica Zocca14.   

Abstract

BACKGROUND: Necrotizing enterocolitis (NEC) is the most common surgical emergency in newborns and it is still a leading cause of death despite the improvements reached in the management of the critically ill neonate. The purpose of this study was to evaluate risk factors, surgical treatments and outcome of surgical NEC.
METHODS: We retrospectively evaluated a multicentric group of 184 patients with surgical NEC over a period of 5 years (2008-2012). Indications to operation were modified NEC Bell stages IIIA or IIIB. The main outcome was measured in terms of survival and postsurgical complications.
RESULTS: Data on 184 patients who had a surgical NEC were collected. The majority of patients (153) had a primary laparotomy (83%); 10 patients had peritoneal drainage insertion alone (5%) and 21 patients had peritoneal drainage followed by laparotomy (12%). Overall mortality was 28%. Patients with lower gestational age (P=0.001), lower birth weight (P=0.001), more extensive intestinal involvement (P=0.002) and cardiac diseases (P=0.012) had a significantly higher incidence of mortality. There was no statistically significant association between free abdominal air on the X-ray and mortality (P=0.407). Mortality in the drainage group was 60%, in the laparotomy group and drainage followed by laparotomy group was of 23-24% (P=0.043). There was a high incidence of stenosis (28%) in the drainage group (P=0.002). On multivariable regression, lower birth weight, feeding, bradycardia-desaturation and extent of bowel involvement were independent predictors of mortality.
CONCLUSIONS: Laparotomy was the most frequent method of treatment (83%). Primary laparotomy and drainage with laparotomy groups had similar mortalities (23-24%), while the drainage alone treatment cohort was associated with the highest mortality (60%) with statistical value (P=0.043). Consequently laparotomy is highly protective in terms of survival rate. Stenosis seemed to be statistically associated with drainage. These findings could discourage the use of peritoneal drainage versus a primary laparotomy whenever the clinical conditions of patients allow this procedure.

Entities:  

Mesh:

Year:  2017        PMID: 28150915     DOI: 10.23736/S0026-4733.17.07159-0

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  4 in total

1.  Clinical characteristic comparison of low birth weight and very low birth weight preterm infants with neonatal necrotizing enterocolitis: a single tertiary center experience from eastern China.

Authors:  Huijia Lin; Shanshan Mao; Liping Shi; Jinfa Tou; Lizhong Du
Journal:  Pediatr Surg Int       Date:  2018-08-20       Impact factor: 1.827

2.  [Clinical guidelines for the diagnosis and treatment of neonatal necrotizing enterocolitis (2020)].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

3.  Impact of an In-House Pediatric Surgery Unit and Human Milk Centered Enteral Nutrition on Necrotizing Enterocolitis.

Authors:  Sonja Zamrik; Federica Giachero; Michael Heldmann; Kai O Hensel; Stefan Wirth; Andreas C Jenke
Journal:  Biomed Res Int       Date:  2018-11-13       Impact factor: 3.411

4.  Laser Speckle Contrast Imaging to Evaluate Bowel Lesions in Neonates with NEC.

Authors:  Kristine Bach Korsholm Knudsen; Joergen Thorup; Rune Broni Strandby; Rikard Ambrus; Linea Landgrebe Ring; Inge Ifaoui
Journal:  European J Pediatr Surg Rep       Date:  2017-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.